Despite the diversity of topics and speakers, some common threads emerged at the joint structural biology meetings in Keystone this past week. First, structural genomics clearly has hit its stride.
Philadelphia, December 1, 2023 – Chimeric Antigen Receptors (CARs) have opened up an exciting new field of therapeutic advancements for rare and difficult-to-treat cancers, as they have the ability to ...
Immuto CEO Faraz Choudhury spoke with Pharmaceutical Executive about his company’s work with focusing on Surface Protein Conformations (SPCs) for target discovery. According to him, traditional target ...
Recent efforts to predict the three-dimensional structure of a protein using AI are progressing as a solution to the protein folding challenge. A protein's three-dimensional structure can be studied ...
– Data support the potential of verekitug’s unique mechanism of action to achieve a differentiated therapeutic effect across a broad range of TSLP-driven severe respiratory diseases – “We continue to ...
Structural variants (SVs) reach up to the megabase scale and account for 10 times as many variants as single nucleotide polymorphisms in the human genome. They contribute to a range of normal and ...
Scientists at the Karolinska Institutet in Sweden have found a new region in the c-Myc oncogene that would allow the development of a binding compound to target it. Their discovery is based on a ...
“There are hundreds of strains of bird flu, and most of them don’t infect humans, or even mammals,” Stephen Cusack told BioWorld. “There are two main reasons for that.” To be able to cause an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results